Thursday, 13 April 2023

MORPHINE (Introduction, Mode of action, Pharmacokinetics, Dosage and Adverse effects)

  INTRODUCTION:-

This drug was first isolated by the German pharmacist “Freidrich Wilhelm Adam Serturner” in 1804 and give the name to this drug is “morphium” (God of sleep). It is a phenanthrene derivative and prototypical strong mu receptor agonist. It is used to control the severe pain. Due to development of hypodermic needle, the use of morphine rapidly increased for relieve of pain. So after the American Civil war, approximately 100000 soldiers got “soldier’s disease” (morphine addiction).



MODE OF ACTION:-

When morphine binds to the mu opioid receptor which is mostly found on the CNS, it activates the alpha G subunit of G protein which is the inhibitory subunit. It goes and inhibit the adenylate cyclase enzyme due to which ATP will not be converted into CAMP, in normal condition CAMP inhibits the potassium channel due to which it blocks the potassium efflux so when CAMP will not formed then there will be no one which inhibit the potassium efflux. Due to continuous potassium efflux it makes the membrane hyperpolarized and stops the action potential due to which pain reduces. And decreased CAMP level also inhibit the Calcium influx due to which it inhibits the release of neurotransmitter from the vesicles of pre-synaptic neuron, which comes in response of noxious stimuli, So it inhibits the signal propagation and produces analgesic effects.

 PHARMACOKINETICS:-

1) Morphine’s absorption occurs in the alkaline environment of the upper intestine and the rectal mucosa. Its bioavailability of morphine is 80 to 100%. Tmax of parental morphine is 15 minutes and oral morphine Tmax is 90 minutes with a Cmax of 283nmol/L. The area under curve (AUC) of morphine is 225-290nmol*h/L and its half-life is 2 to 3 hours.

2) Morphine’s volume of distribution is 5.31L/kg while morhine-6-glucuronide’s volume of distribution is 3.61L/kg.

3) Morphine’s protein binding is 35%, morphine-3-glucuronide’s protein binding is 10% and morphine-6-glucuronide’s protein binding is 15%.

4) Morphine is 90% metabolized by the glucuronidation by UGT2B7 and sulfation at positions 3 and 6. It can also be metabolized into normorphine, morphine ethereal sulfate and codeine.

5) Morphine’s 70-80% of administered dose is excreted within 48hrs. It is mainly eliminated via urine along with 2-10% of administered dose recovered as unchanged parent drug and 7-10% morphine’s dose is eliminated via feces.

DOSAGE:-

ORAL:-short-acting oral dose for severe and chronic pain in adults is 10-30 mg Q4H.

I.M or S.C:-5-20 mg (usually10 mg) Q4H.

I.V:-initial dose is 4 mg-10 mg slowly over 4-5 minutes Q4H. Daily dose range is 12-120 mg.

 ADVERSE EFFECTS:-

1) Miosis

2) Respiratory depression

3) Physical dependence

4) Orthostatic hypotension

5) Increased intracranial tension

6) Nausea

7) Sedation

8) Euphoria



No comments:

Post a Comment

PETHIDINE (Introduction, Mode of action, Pharmacokinetics, Dosage and Adverse effects)

  INTRODUCTION:- Pethidine is the street name of meperidine. It was firstly synthesized as atropine substitute in 1939. It is relatively w...